These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficacy of two leukotriene antagonists in rat traumatic shock. Levitt MA; Lefer AM Methods Find Exp Clin Pharmacol; 1987 May; 9(5):269-73. PubMed ID: 3613754 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock. Hock CE; Lefer AM Circ Shock; 1985; 17(4):263-72. PubMed ID: 3841503 [TBL] [Abstract][Full Text] [Related]
7. Role of the splanchnic visceral organs in development of tolerance to traumatic shock. Araki H; Sollott SJ; Lefer AM J Trauma; 1980 Dec; 20(12):1046-51. PubMed ID: 7452749 [TBL] [Abstract][Full Text] [Related]
8. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock. Aoki N; Johnson G; Siegfried MR; Lefer AM Eicosanoids; 1989; 2(3):169-74. PubMed ID: 2534278 [TBL] [Abstract][Full Text] [Related]
9. Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock. Karasawa A; Rochester JA; Lefer AM Methods Find Exp Clin Pharmacol; 1990 May; 12(4):231-7. PubMed ID: 2165204 [TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock. Hock CE; Lefer AM Circ Shock; 1984; 14(3):159-68. PubMed ID: 6542462 [TBL] [Abstract][Full Text] [Related]
11. Protective actions of nafazatrom in traumatic shock. Lefer AM; Messenger M Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831 [TBL] [Abstract][Full Text] [Related]
12. Salutary effects of anisodamine in murine traumatic shock. Hock CE; Su JY; Lefer AM Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878 [TBL] [Abstract][Full Text] [Related]
13. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock. Bitterman H; Smith BA; Lefer AM Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378 [TBL] [Abstract][Full Text] [Related]
14. Correlation of plasma lysosomal enzyme levels with hepatic reticuloendothelial function after trauma. Loergering DJ; Kaplan JE; Saba TM Proc Soc Exp Biol Med; 1976 May; 152(1):42-6. PubMed ID: 1265077 [TBL] [Abstract][Full Text] [Related]
15. Effect of voluntary exercise on resistance to trauma in rats. Asoh T; Takeuchi Y; Tsuji H Circ Shock; 1986; 20(4):259-67. PubMed ID: 3791575 [TBL] [Abstract][Full Text] [Related]
16. Protective effects of KW-3635, a novel thromboxane A2 antagonist, in murine traumatic shock. Karasawa A; Taylor PA; Lefer AM Eur J Pharmacol; 1990 Jun; 182(1):1-8. PubMed ID: 2401310 [TBL] [Abstract][Full Text] [Related]
17. [Hemodynamics and lysosomal hydrolases in burn shock]. Kochetygov NI; Remizova MI; Kulikov AM Patol Fiziol Eksp Ter; 1980; (1):31-6. PubMed ID: 7375154 [No Abstract] [Full Text] [Related]
18. Beneficial effects of oligotide, a novel oligodeoxyribonucleotide, in murine traumatic shock. Skurk C; Nuss C; Lefer AM Shock; 1995 Jan; 3(1):13-20. PubMed ID: 7531603 [TBL] [Abstract][Full Text] [Related]
19. Protective effects of a novel thromboxane analog in lethal traumatic shock. Lefer AM; Araki H; Smith JB; Nicolaou KC; Magolda RL Prostaglandins Med; 1979 Sep; 3(3):139-46. PubMed ID: 552102 [TBL] [Abstract][Full Text] [Related]